177lu-psma-617
bayer,novartis
[]
#asco2022 177lu-psma treatment is clinically feasible and well tolerated in pts who received prior radium-223. interim results of the multi enter ralu study 
Professor in Nuclear Medicine, Senior Managing attending, Deputy director at the department of Nuclear Medicine, university hospital Münster